Global | Publication | October 2018
In April 2016, the European Parliament adopted the General Data Protection Regulation (GDPR) to modernize its data protection legislation. As of May 25, 2018, the Data Protection Directive was thus repealed and replaced by the GDPR, while all member states legislation became subject to review to be aligned with the GDPR, leading to major modifications of the rules that prevailed prior to the GDPR coming into force.
For research trials, enacting the GDPR had a number of implications, both for sponsors, contract research organizations (CROs) and trial sites located in the European Union (EU), and for some foreign CROs and sponsors, which now need to comply with various obligations failing which they may be exposed to heavy fines and other legal recourses.
Click here to read about the various obligations that must be complied with.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023
